Diagnos Laboratorium Utama PT Tbk - Asset Resilience Ratio

Latest as of June 2025: 0.32%

Diagnos Laboratorium Utama PT Tbk (DGNS) has an Asset Resilience Ratio of 0.32% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check DGNS strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

Rp959.59 Million

≈ $56.23K USD Cash + Short-term Investments

Total Assets

Rp304.08 Billion

≈ $17.82 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how Diagnos Laboratorium Utama PT Tbk's Asset Resilience Ratio has changed over time. See Diagnos Laboratorium Utama PT Tbk net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Diagnos Laboratorium Utama PT Tbk's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see DGNS stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rp0.00	0%
Short-term Investments	Rp959.59 Million	0.32%
Total Liquid Assets	Rp959.59 Million	0.32%

Asset Resilience Insights

Limited Liquidity: Diagnos Laboratorium Utama PT Tbk maintains only 0.32% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Diagnos Laboratorium Utama PT Tbk Industry Peers by Asset Resilience Ratio

Compare Diagnos Laboratorium Utama PT Tbk's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fleury S.A. SA:FLRY3	Diagnostics & Research	16.06%
Wuhan Thalys Med Tech Co Ltd SHG:603716	Diagnostics & Research	0.12%
Spectral Med Inc TO:EDT	Diagnostics & Research	11.67%
Bcal Diagnostics Ltd AU:BDX	Diagnostics & Research	0.00%
Genetic Signatures Ltd AU:GSS	Diagnostics & Research	60.91%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for Diagnos Laboratorium Utama PT Tbk (2021–2024)

The table below shows the annual Asset Resilience Ratio data for Diagnos Laboratorium Utama PT Tbk.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.32%	Rp959.59 Million ≈ $56.23K	Rp300.02 Billion ≈ $17.58 Million	-0.30pp
2023-12-31	0.62%	Rp1.70 Billion ≈ $99.37K	Rp271.48 Billion ≈ $15.91 Million	-0.44pp
2022-12-31	1.06%	Rp2.54 Billion ≈ $148.99K	Rp239.94 Billion ≈ $14.06 Million	-1.63pp
2021-12-31	2.69%	Rp6.51 Billion ≈ $381.30K	Rp241.98 Billion ≈ $14.18 Million	--

pp = percentage points

About Diagnos Laboratorium Utama PT Tbk

JK:DGNS Indonesia Diagnostics & Research

Market Cap

$17.43 Million

Rp297.50 Billion IDR

Market Cap Rank

#25561 Global

#546 in Indonesia

Share Price

Rp238.00

Change (1 day)

-3.25%

52-Week Range

Rp140.00 - Rp328.00

All Time High

Rp1408.74